戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              1H MRS could serve as a sensitive in vivo surrogate indi
2                                              1H-MRS of the medial prefrontal cortex was obtained in 2
3                                              1H-MRS scans were acquired to assess pgACC glutamate lev
4                                              1H-MRS showed adequate discriminant validity, but limite
5                                              1H-MRS spectra were collected at baseline and after trea
6 shop participants for the use of DCE-MRI and 1H MRS in the clinical assessment of antitumor therapies
7                          We measured MRI and 1H-MRS changes.
8 ecreased in relation to the pre-HSCT MRI and 1H-MRS.
9                                  31P-MRS and 1H-MRS of tumor extracts showed a significant decrease i
10 ent and myocardial function were assessed by 1H MRS imaging and MRI at 3 T.
11 tamate and glutamine (Glx), were measured by 1H MRS in the left dorsolateral prefrontal cortex (l-DLP
12      Intensities of the purine resonance, by 1H MRS (7.5-8.5 ppm), and of NTP, by 31P MRS, were deter
13                             gastrocnemius by 1H-MRS and HPLC to compare signal quality and convergent
14         However, carnosine quantification by 1H-MRS has some potential limitations that warrant a tho
15         In individual and group comparisons, 1H MRS described a metabolite profile in the hippocampi
16             In this study, the age-dependent 1H MRS profile of transgenic AD mice was compared to tha
17                                  Results for 1H-MRS did not differ significantly between patients and
18                                    Data from 1H MRS and phosphorus-31 (31P) MRS were acquired for dep
19                        Results obtained from 1H-MRS showed no significant difference in either glutam
20                          Spatially localised 1H-MRS can be used to measure total creatine non-invasiv
21 ccipital cortex by using spatially localized 1H-MRS.
22 s a critical factor in the interpretation of 1H MRS findings in psychosis spectrum disorders.
23 We validated this technique by comparison of 1H-MRS values of creatine with biopsy assays in an anima
24 mance of this test and the potential role of 1H-MRS in the in-vivo assessment of placental function t
25 ny of the metabolites measured by 31P-MRS or 1H-MRS there was a dose-response relationship with aura
26 oxel proton magnetic resonance spectroscopy (1H MRS) has shown abnormalities in patients with tempora
27 ther proton magnetic resonance spectroscopy (1H MRS) measures of the low-field purine resonance, whic
28 sing proton magnetic resonance spectroscopy (1H MRS), this study assessed whether dysregulation of th
29 bral proton magnetic resonance spectroscopy (1H MRS).
30 d single-voxel proton magnetic spectroscopy (1H-MRS) at 4 Tesla to examine GABA relative to total cre
31  not been considered in proton spectroscopy (1H-MRS) studies and it has not been studied in cerebral
32  and proton magnetic resonance spectroscopy (1H-MRS) as standard follow-up after HSCT with cord blood
33      Proton magnetic resonance spectroscopy (1H-MRS) can detect a choline resonance that is largely d
34 sively with magnetic resonance spectroscopy (1H-MRS) changes in the concentrations of intracellular (
35 ard, proton magnetic resonance spectroscopy (1H-MRS) has been used as a non-invasive alternative to q
36 sing proton magnetic resonance spectroscopy (1H-MRS) in healthy subjects.
37 ed hydrogen magnetic-resonance spectroscopy (1H-MRS) on a clinical (1.5 T) magnetic-resonance-imaging
38      Proton magnetic resonance spectroscopy (1H-MRS) spectra were acquired at 3 Tesla in the anterior
39      Proton magnetic resonance spectroscopy (1H-MRS) studies in individuals with ASD have documented
40 r of proton magnetic resonance spectroscopy (1H-MRS) studies in patients with first-episode psychosis
41 oxel proton magnetic resonance spectroscopy (1H-MRS) studies of patients with schizophrenia have foun
42  for proton magnetic resonance spectroscopy (1H-MRS) studies reporting glutamate, glutamine or Glx in
43 (TE) proton magnetic resonance spectroscopy (1H-MRS) to measure skeletal muscle acetylcarnitine conce
44 used proton magnetic resonance spectroscopy (1H-MRS) to study in vivo the integrity of axonal fibers
45 with proton magnetic resonance spectroscopy (1H-MRS).
46 ized proton magnetic resonance spectroscopy (1H-MRS).
47                                           SV 1H-MRS provides useful biochemical information about the
48 l proton magnetic resonance spectroscopy (SV 1H-MRS), coupled with supervised pattern recognition (PR
49  and negative peaks, from a widely tested SV 1H-MRS human brain tumour database.
50                         For this, we used SV 1H-MRS data with positive and negative peaks, from a wid
51 tudy used a cross-sectional design using 3-T 1H-MRS in participants not taking MDD medication recruit
52             Cross-sectional design using 3-T 1H-MRS in participants recruited from university-based p
53                                    A long-TE 1H-MRS protocol was implemented for successful detection
54                           We applied long-TE 1H-MRS to measure acetylcarnitine in endurance-trained a
55                     The results suggest that 1H-MRS detects altered levels of mI, NAA, Glx and Cho in
56 , would be associated with a decrease in the 1H-MRS choline resonance.
57 tamate ratio, it is not clear which of these 1H-MRS indices of glutamatergic neurotransmission is alt
58                 Quantitative short echo time 1H MRS identified abnormalities in 87% of patients with
59 , and 15 MRI-negative TLE patients underwent 1H MRS at an echo time of 30 msec on a 1.5-T GE Signa sc
60 olerant control subjects (n = 128) underwent 1H-MRS to measure IMCL and muscle volume, whole-body ins
61          The current longitudinal study used 1H-MRS to investigate the developmental trajectory of pr
62 nse to treatment might be predicted by using 1H MRS.
63 cortical glutamate, mI and tCho levels using 1H-MRS.
64 n GABA in similar brain regions in MDD using 1H-MRS suggest a common reduction in cortical GABA among
65                       HFC was measured using 1H-MRS prior to test meal administration (before time 0)
66                             We used in vitro 1H-MRS to verify signal linearity and possible noise sou
67         Inclusion criteria were single voxel 1H-MRS studies reporting glutamate, glutamine or Glx val
68 use models of AD that have been studied with 1H MRS, APP-PS1 mice seem to best match the neurochemica
69 a and healthy controls with 31P-MRS and with 1H-MRS.
70 easuring acetylcarnitine concentrations with 1H-MRS is feasible on clinical MR scanners and support t